UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006528 |
|---|---|
| Receipt number | R000007698 |
| Scientific Title | Multicenter phase II study of adding bi-weekly cetuximab to oral S-1 therapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies |
| Date of disclosure of the study information | 2011/10/13 |
| Last modified on | 2016/11/16 08:56:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/12 17:54:04 | ||
| 2 | Update | 2011/12/01 18:43:11 | Recruitment status |
|
| 3 | Update | 2011/12/01 18:48:17 | Acronym Acronym |
|
| 4 | Update | 2012/12/05 22:19:40 | Email1 |
|
| 5 | Update | 2016/06/29 20:22:19 | UMIN ID1 |
|
| 6 | Update | 2016/11/16 08:48:47 | Email Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary person or sponsor Organization |
|
| 7 | Update | 2016/11/16 08:49:14 | Key inclusion criteria |
|
| 8 | Update | 2016/11/16 08:56:16 | Recruitment status |
